Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 7, 1997, Pages 729-730

  Tzivras, M ^a   Konstandinidis, A ^a   Hatzis, G ^a   Paraskeva, K ^a   Skandalis, N ^a   Archimandritis, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; ULCERATIVE COLITIS;

EID: 0030852115     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199707000-00016     Document Type: Article

References (4)